By Kent Smith, DDS, DABDSM There is a concerning paradigm shift sprouting in dental sleep medicine: direct-to-physician and direct-to-consumer mail-order custom oral appliance therapy workflows. On behalf of myself and other dental sleep medicine practitioners, I am … [Read more...]
GLP-1 Medications Show Promise as First Drug Therapy for Sleep Apnea
By Alyx Arnett A class of weight-loss medications is gaining attention for its potential to become a pharmacological treatment option for obstructive sleep apnea (OSA) in patients with obesity. A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and … [Read more...]
Acoustic Resonance Therapy Shows Promise in Treating Chronic Insomnia
Summary: A pilot study from Stanford Medicine and SoundHealth explored the use of acoustic resonance therapy as a new, non-invasive treatment for chronic insomnia. The therapy involved delivering personalized binaural spatial audio through a specialized headband, tailored to each … [Read more...]
AASM’s New RLS Guidelines Recommend Peroneal Nerve Stimulation Therapy
Summary: The American Academy of Sleep Medicine (AASM) has issued new guidelines for the treatment of restless legs syndrome (RLS), recognizing high-frequency bilateral peroneal nerve stimulation, such as the Nidra TOMAC system from Noctrix Health, as a non-pharmacologic … [Read more...]
FDA Clears Sleep Apnea Oral Appliance for Bruxism Therapy Too
Summary: The Slow Wave DS8 oral appliance, initially FDA-cleared for mild to moderate OSA, has now received clearance for the treatment of sleep bruxism. Marketed as BROSA for bruxism, the device offers a comprehensive solution for both conditions by relaxing jaw muscles and … [Read more...]
XII Medical Raises $45M to Advance Neuromodulation Therapy for OSA
Summary: XII Medical Inc, a clinical-stage medical technology company focused on developing neuromodulation therapies for obstructive sleep apnea (OSA), has raised $45 million in Series B equity financing. The funding, led by Omega Funds with participation from new and existing … [Read more...]
FDA Approves Next-Gen Inspire Therapy System for OSA
Summary: Inspire Medical Systems announced it has received FDA approval for its next-generation Inspire V therapy system, which includes a new neurostimulator and Bluetooth-enabled patient remote and physician programmer. The company is preparing for a commercial launch in the … [Read more...]
Inspire Secures Reimbursement for OSA Therapy in France
Summary: Inspire Medical Systems, a company specializing in minimally invasive solutions for obstructive sleep apnea, announced the approval of reimbursement for its Inspire therapy in France. The therapy, which received European Conformity Marking in 2010, has already secured … [Read more...]
Alkermes Reports Q2 Advances in Narcolepsy Therapy With ALKS 2680 Results
Summary: Alkermes reported its Q2 2024 financial performance and advances in the development of narcolepsy treatments, particularly with the investigational drug ALKS 2680. The company highlighted its financial position, double-digit growth, and progress in its neuroscience … [Read more...]
Zzoma Positional Sleep Apnea Therapy Now on Parachute Health
Summary: Sleep Specialists announced that its FDA-cleared device, Zzoma, for treating mild to moderate positional sleep apnea, is now available for ordering on Parachute Health, an online platform for medical equipment and supplies. This move aims to simplify and streamline the … [Read more...]